Navigation Links
CureLauncher is a New Website That Connects Patients to Trials Across the U.S.
Date:12/6/2012

Bloomfield Hills, MI (PRWEB) December 06, 2012

CureLauncher is bringing people together to advance new treatments for cancer.

Many people don’t know there’s free treatment available at world-class medical sites across America. Only CureLauncher.com translates the complex, medical terminology into easy to understand English. It provides the entry questions to determine if a trial is appropriate for anyone’s specific condition.

People can submit a Request Form to participate or call cureLauncher directly to see if they qualify. This service is entirely free to all users.    

In addition to connecting patients to clinical trials, cureLauncher is also advancing a new treatment for breast cancer, even if the cancer has spread to other parts of the body.

Dr. Lee Roy Morgan is an esteemed cancer researcher and has been awarded research funding by the National Institutes of Health (NIH) for his work. However, government funding cuts to the NIH may prevent Dr. Morgan from advancing his new breast cancer treatment; abbreviated name is DM-CHOC-PEN.

Donations made on cureLauncher will allow Dr. Morgan to continue developing this cure.

“We are working through the FDA to move this program forward as quickly as possible” said Dr. Morgan. Ninety one percent of all money donated on cureLauncher will be used to make drug supplies for the next clinical trial. “These donations will make a huge difference toward our goal of improving cancer patients’ lives”.

CureLauncher creates a personal connection to advancing new cancer treatments. Each person who donates $25 or more to Dr. Morgan’s research can write a personal and confidential email and receive Dr. Morgan's reply.

CureLauncher puts the most money possible directly into new cancer treatments. “Each person can see exactly where their contribution is used and be confident that 91% of that money is going directly into advancing a new cancer treatment”, said cureLauncher President, Stephen Goldner, JD, RAC. CureLauncher.com lets you see a new breast cancer treatment in development and connect with the dedicated scientists who are saving lives.    

To learn more, visit http://www.curelauncher.com

Find. Fund. Cure.

About CureLauncher
CureLauncher.com is an online community dedicated to funding new cancer treatments. It connects patients to lifesaving clinical trials and generates support for new cancer treatments in a way never before possible. Advocates of the research connect with each other and leading medical professionals to advance new treatments for cancer.

Read the full story at http://www.prweb.com/releases/cureLauncher/Clinical_Trial_Access/prweb10210154.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Only 16% of Donations go to New Cancer Treatments in Some Charities. With cureLauncher, 91% of Contributions Go Directly to New Cures for Cancer.
2. BioRestorative Therapies Announces Launch of New Website
3. Prostate Cancer Medical Websites: Friend Or Foe?
4. A New Dawn in Cosmetics Coverage: Cosmetics Design Launches Asia-Pacific News Website
5. Clinical Site Services, Industry Leader in Patient Enrollment Solutions, Announces New Website
6. Critical Process Filtration Announces New Website and Expanded Literature Library
7. JH Technologies Announces Launch of Their New Website
8. Berkshire Corporation Offers Live Chat For Americas Website and Shopping Cart
9. Trade Show Display Company GLM Displays Increase Sales with New E-commerce Website
10. Pittcon 2013 Launches New Website
11. Comprehensive Resource for Food Safety Diagnostics – Romer Labs Launches New Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , ... December 01, 2016 , ... ... long-term client Nanowear on their recent FDA Class II 510(k) clearance for their ... significant hurdle in commercializing remote cardiac monitoring devices that rely on cloth-based nanosensors. ...
(Date:12/2/2016)... bioLytical Laboratories, a world leader in rapid infectious disease tests, introduced the Company,s newest ... members. (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) Continue Reading ... ... , , bioLytical was invited ... introduce the INSTI HIV Self Test to 350 pharmacy representatives in Nairobi ...
(Date:11/30/2016)... Nov. 30, 2016 Biotest Pharmaceuticals Corporation (BPC), ... to announce the addition of its newest plasma collection ... Nebraska . The 15,200 square foot state-of-the-art facility ... 2016 and brings the total number of BPC,s plasma ... Carlisle , BPC,s Chief Executive Officer said "We are ...
(Date:11/30/2016)... November 2016   Merck , ein ... Unterzeichnung einer Reihe von Vereinbarungen mit Evotec ... AG Screeningleistungen für Mercks Palette genetischer Reagenzien ... auf diese Bibliotheken in Kombination mit Evotecs ... Weg zur Ermittlung und Erforschung neuer Arzneimitteltargets.    ...
Breaking Biology Technology:
(Date:11/29/2016)... CANNES, France , November 29, 2016 Nearly ... Continue Reading ... ... System is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric ...
(Date:11/21/2016)... Nov. 21, 2016   Neurotechnology , a ... technologies, today announced that the MegaMatcher On Card ... submitted for the NIST Minutiae Interoperability Exchange ... the mandatory steps of the evaluation protocol. ... continuing test of fingerprint templates used to establish ...
(Date:11/15/2016)... 2016  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... the gut microbiome, today announced the pricing of ... its common stock and warrants to purchase 50,000,000 ... to the public of $1.00 per share and ... the offering, excluding the proceeds, if any from ...
Breaking Biology News(10 mins):